Fresenius Kabi Compounding, LLC: acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Se
Read the official notice at FDA (drug) →
Get alerts for Fresenius Kabi Compounding
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Fresenius Kabi Compounding, LLC
- Product
- acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
- Reason / hazard
- Lack of Assurance of Sterility
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- US Nationwide.
- Recall initiated
- 2026-02-05
- Code info
- Lot # C274-000049124, Exp Date: 28-Feb-26.
- Product quantity
- 1057 bags
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Canton
- State
- MA
- Country
- United States
- Event id
- 98391
Free daily digest + "My products" watchlist